Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Borghetti

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 19, 2020
Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 TrialMarta Maddalo, Paolo Borghetti, Davide Tomasini, et al.
Cancers|January 21, 2023
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS StudySalvatore Cozzi, Alessio Bruni, Maria Paola Ruggieri, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2016
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck CancerMichela Buglione, Marta Maddalo, Renzo Corvò, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Alessio Bruni, Vieri Scotti, Maria Alessia Zerella, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
Elife|April 24, 2024
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE studyMarco Bergamini, Alberto Dalla Volta, Carlotta Palumbo, et al.
La Radiologia Medica|October 10, 2022
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative studyPaolo Borghetti, Jacopo Branz, Giulia Volpi, et al.
Current Oncology (Toronto, Ont.)|July 27, 2022
Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung CancerMarco Bertolini, Valeria Trojani, Andrea Botti, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2025
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumabFrancesco Cortiula, Talia Shentzer Kutiel, Melinda L Hsu, et al.
Cancers|May 14, 2022
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic TreatmentAndrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|March 19, 2020
Cetuximab and Radiation Therapy Versus Cisplatin and Radiation Therapy for Locally Advanced Head and Neck Cancer: Long-Term Survival and Toxicity Outcomes of a Randomized Phase 2 TrialMarta Maddalo, Paolo Borghetti, Davide Tomasini, et al.
Cancers|January 21, 2023
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS StudySalvatore Cozzi, Alessio Bruni, Maria Paola Ruggieri, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2016
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck CancerMichela Buglione, Marta Maddalo, Renzo Corvò, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Alessio Bruni, Vieri Scotti, Maria Alessia Zerella, et al.
British Journal of Cancer|April 28, 2017
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric studyLuca Triggiani, Filippo Alongi, Michela Buglione, et al.
Elife|April 24, 2024
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE studyMarco Bergamini, Alberto Dalla Volta, Carlotta Palumbo, et al.
La Radiologia Medica|October 10, 2022
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative studyPaolo Borghetti, Jacopo Branz, Giulia Volpi, et al.
Current Oncology (Toronto, Ont.)|July 27, 2022
Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung CancerMarco Bertolini, Valeria Trojani, Andrea Botti, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2025
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumabFrancesco Cortiula, Talia Shentzer Kutiel, Melinda L Hsu, et al.
Cancers|May 14, 2022
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic TreatmentAndrea Emanuele Guerini, Alessandra Tucci, Filippo Alongi, et al.
Pageof 13